Method for deactivating viruses in blood component containers

Details Method for deactivating viruses in blood component containers Method for deactivating viruses in blood component containers

1993-09-15

1994-12-27

Wityshyn, Michael G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514886, 514887, 435236, 424 9464, A61K 3710, A61K 37547

Patent

active

053766334

ABSTRACT:
The present invention provides a method for inhibiting viral proliferation by preventing or inhibiting viral replication or killing the viruses on contact. Viral replication is prevented or inhibited through the use of serine protease inhibitors, their analogs, salts, conjugates or derivatives.

REFERENCES:
patent: 4829052 (1989-05-01), Glover et al.
patent: 4891356 (1990-01-01), Szabo
patent: 4916117 (1990-04-01), Cezdey et al.
patent: 5093316 (1992-03-01), Cezdey et al.
patent: 5134119 (1992-06-01), Cezdey et al.
patent: 5151509 (1992-09-01), Kotwal et al.
Ebina et al, Microbiol. Immunol. vol. 35, No. 7, pp. 583-588, 1991.
Korant et al, Biol. Chem. Hopper-Seyler, vol. 369, Supp. pp. 281-286, May 1988.
Weber et al, Science, vol. 243, pp. 928-931, 17 Feb. 1989.
Bazan et al, FEBS Letter, vol. 249, No. 1, pp. 5-7, May 1989.

Affiliated with

Also associated with

Rating

Method for deactivating viruses in blood component containers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for deactivating viruses in blood component containers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for deactivating viruses in blood component containers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-919800